Home
>
National Drug Code (NDC)
>
Terazosin Hydrochloride Anhydrous
Terazosin Hydrochloride Anhydrous - 0378-1570-10 - (terazosin hydrochloride anhydrous)
Drug Information of Terazosin Hydrochloride Anhydrous
| Product NDC: | 0378-1570 |
| Proprietary Name: | Terazosin Hydrochloride Anhydrous |
| Non Proprietary Name: | terazosin hydrochloride anhydrous |
| Active Ingredient(s): | 10 mg/1 & nbsp; terazosin hydrochloride anhydrous |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Terazosin Hydrochloride Anhydrous
| Product NDC: | 0378-1570 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075140 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130222 |
Package Information of Terazosin Hydrochloride Anhydrous
| Package NDC: | 0378-1570-10 |
| Package Description: | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-1570-10) |
NDC Information of Terazosin Hydrochloride Anhydrous
| NDC Code | 0378-1570-10 |
| Proprietary Name | Terazosin Hydrochloride Anhydrous |
| Package Description | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-1570-10) |
| Product NDC | 0378-1570 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | terazosin hydrochloride anhydrous |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20130222 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | TERAZOSIN HYDROCHLORIDE ANHYDROUS |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
